The following information is obtained from various newswires,
published medical journal articles, and medical conference presentations.
Company: Roche
Approval Status: Approved Februrary 1997
Treatment for: vaginal yeast infections
General Information
FEMSTAT One has been approved for the treatment of vulvovaginal infections caused by Candida albicans.